LHDX News and Press, Lucira Health Inc. From 04/09/21

Celcuity (CELC) +55% on licensing agreement up to $340M for breast cancer treatment gedatolisib.Affimed N.V. (AFMD) +29% on positive data from NK cells + AFM13 in solid tumors.Greenwich LifeSciences (GLSI) +29% on robust immune response Phase IIb data in breast cancer.Gulf Reso...

Lucira Health (LHDX) shares surge 14% premarket on news that its Lucira molecular test kit can successfully identify the “double mutant” variant of COVID-19. The “double mutant” variant was first identified in India on March 24, and found in California on...

LUCIRA COVID-19 All-In-One Test Kit reactive to at least 99.9% of all known COVID-19 virus strains Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits,...

Looking For The Best Health Care Stocks To Buy? 4 Making Waves Now It comes as no surprise that the health care sector would be receiving more attention during a pandemic. By extension, this could also include more investors looking for the top health care stocks now. Why? Well,...

Bank of America Securities has initiated the coverage of Lucira Health ([[LHDX]] -6.9%) with a neutral rating as the firm, despite being optimistic over the company’s technology, questions the long-term viability of the market for COVID-19 testing.The maker of LUCIRA COVID- 19 All- In-...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Investors have a variety of events and developments to focus on next week. The impact of the pending FDA approval on Joh...

Two IPOs are scheduled to raise $1.3 billion in the week ahead. Street research is expected for 14 companies. Lock-up periods will be expiring for six companies. For further details see: U.S. IPO Week Ahead: Health Insurer Oscar Health Leads A 2 IPO Week

Gainers: Vaccinex VCNX +148%, Evolus EOLS +60%, TransEnterix (TRXC) +17%, BioVie (BIVI) +16%, Auris Medical (EARS) +13%.Losers: China SXT Pharmaceuticals SXTC -21%, Motus GI MOTS -16%, 180 Life Sciences ATNF -11%, Luci...

Looking For The Best Health Care Stocks To Watch Right Now? You can’t deny that health care stocks have been in the limelight as of late. Throughout this near-year-long pandemic, the general public has and continues to hear about the importance of health. For investors, t...

--- Lab-quality results in 30 minutes or less --- Lucira Health, Inc. (Nasdaq: LHDX), today announced that U.S. physicians and healthcare providers can now order Lucira COVID-19 All-In-One Test Kits online from lucirahealth.com . This U.S. made and manufactured produ...